Yinbang Clad MaterialLtd Balance Sheet Health
Financial Health criteria checks 2/6
Yinbang Clad MaterialLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥2.6B, which brings its debt-to-equity ratio to 156.3%. Its total assets and total liabilities are CN¥5.1B and CN¥3.4B respectively. Yinbang Clad MaterialLtd's EBIT is CN¥205.2M making its interest coverage ratio 2.2. It has cash and short-term investments of CN¥370.8M.
Key information
156.3%
Debt to equity ratio
CN¥2.64b
Debt
| Interest coverage ratio | 2.2x |
| Cash | CN¥370.84m |
| Equity | CN¥1.69b |
| Total liabilities | CN¥3.38b |
| Total assets | CN¥5.06b |
Recent financial health updates
Yinbang Clad MaterialLtd (SZSE:300337) Has A Somewhat Strained Balance Sheet
Oct 16
Is Yinbang Clad MaterialLtd (SZSE:300337) A Risky Investment?
Jul 12Recent updates
Yinbang Clad MaterialLtd (SZSE:300337) Has A Somewhat Strained Balance Sheet
Oct 16Yinbang Clad Material Co.,Ltd (SZSE:300337) Might Not Be As Mispriced As It Looks
Sep 16There's Been No Shortage Of Growth Recently For Yinbang Clad MaterialLtd's (SZSE:300337) Returns On Capital
Aug 21Is Yinbang Clad MaterialLtd (SZSE:300337) A Risky Investment?
Jul 12If EPS Growth Is Important To You, Yinbang Clad MaterialLtd (SZSE:300337) Presents An Opportunity
Jun 26There May Be Reason For Hope In Yinbang Clad MaterialLtd's (SZSE:300337) Disappointing Earnings
Apr 04The Market Lifts Yinbang Clad Material Co.,Ltd (SZSE:300337) Shares 38% But It Can Do More
Mar 06Financial Position Analysis
Short Term Liabilities: 300337's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 300337's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥2.2B).
Debt to Equity History and Analysis
Debt Level: 300337's net debt to equity ratio (134.4%) is considered high.
Reducing Debt: 300337's debt to equity ratio has increased from 66.9% to 156.3% over the past 5 years.
Debt Coverage: 300337's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300337's interest payments on its debt are not well covered by EBIT (2.2x coverage).